Search Results

Dabrafenib 100mg 100mg  | Purity Not Available

Adooq Bioscience

Dabrafenib is a potent and selective inhibitor of B-RAF protein kinase carrying V600E mutation, currently in clinical trial.

More Information Supplier Page

Saquinavir 50mg 50mg  | Purity Not Available

Adooq Bioscience

Saquinavir is a protease inhibitor. Proteases are enzymes that cleave protein molecules into smaller fragments. Saquinavir inhibits both HIV-1 and HIV-2 proteases.

More Information Supplier Page

Saquinavir 25mg 25mg  | Purity Not Available

Adooq Bioscience

Saquinavir is a protease inhibitor. Proteases are enzymes that cleave protein molecules into smaller fragments. Saquinavir inhibits both HIV-1 and HIV-2 proteases.

More Information Supplier Page

Saquinavir 200mg 200mg  | Purity Not Available

Adooq Bioscience

Saquinavir is a protease inhibitor. Proteases are enzymes that cleave protein molecules into smaller fragments. Saquinavir inhibits both HIV-1 and HIV-2 proteases.

More Information Supplier Page

Saquinavir 100mg 100mg  | Purity Not Available

Adooq Bioscience

Saquinavir is a protease inhibitor. Proteases are enzymes that cleave protein molecules into smaller fragments. Saquinavir inhibits both HIV-1 and HIV-2 proteases.

More Information Supplier Page

DZNep 5mg 5mg  | Purity Not Available

Adooq Bioscience

3 Deazaneplanocin A (DZNep) is a cyclopentenyl analog of 3-deazaadenosine, originally synthesized as an inhibitor of S-adenosyl-L-homocysteine hydrolase.

More Information Supplier Page

Dabrafenib 50mg 50mg  | Purity Not Available

Adooq Bioscience

Dabrafenib is a potent and selective inhibitor of B-RAF protein kinase carrying V600E mutation, currently in clinical trial.

More Information Supplier Page

Evacetrapib (LY2484595) 10mg 10mg  | Purity Not Available

Adooq Bioscience

Evacetrapib (LY2484595) is a drug that inhibits cholesterylester transfer protein, which transfers and thereby increases high-density lipoprotein and lowers low-density lipoprotein.

More Information Supplier Page

E-7050 (Golvatinib) 50mg 50mg  | Purity Not Available

Adooq Bioscience

E7050 (also known as golvatinib is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity.

More Information Supplier Page